Ezetimibe analogue and preparation method thereof

A technology for ezetimibe and analogs, applied in the field of ezetimibe analogs and their preparation, to achieve the effects of inhibiting absorption and increasing permeability

Inactive Publication Date: 2013-08-21
DONGHUA UNIV +1
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The benzene ring and the branched chain benzene ring on the N of the lactam are pharmacophore, the substitution of the benzene ring on the N has no great in

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ezetimibe analogue and preparation method thereof
  • Ezetimibe analogue and preparation method thereof
  • Ezetimibe analogue and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] 1. Synthesis of intermediate 3d (2,2,2-trifluoro-N-(4-fluorophenyl)acetimidoyl chloride):

[0038]

[0039] Add Ph 3 P (33mmol, 8.655g), Et 3 N (13.2mmol, 1.825mL), CCl 4 (55mmol, 5.275mL) and trifluoroacetic acid (11mmol, 1.254g), after the reaction bottle was stirred in an ice bath for 10 minutes, p-fluoroaniline (11mmol, 1.221g) was added to the reaction bottle with CCl 4 (55mmol, 5.275mL) solution, the mixture was reacted under reflux for 3h, the solvent was spin-off under reduced pressure, the solid mixture obtained was washed with n-hexane and filtered, and the filtrate was concentrated and distilled under reduced pressure to obtain product 3d, ((E) -4-fluoro-N-trifluoroacetal) aniline, the NMR data of this compound are consistent with those reported in the literature (J.Org.Chem.1993, 58, 32).

[0040] 2. Synthesis of intermediate 5d:

[0041] (S,Z)-4-benzyl-3-(4,4,4-trifluoro-3-(4-fluorophenylamino)but-2-enoyl)oxazolidin-2-one(5d).

[0042]

[0043]A...

Embodiment 2

[0071] 1. Inhibitory activity of Ezetimibe analogues on the absorption of exogenous cholesterol at the cellular level.

[0072] Tested cells: Caco-2

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an ezetimibe analogue and a preparation method thereof. The structure general formula of the ezetimibe analogue is shown in a structural formula, wherein in the formula, R1, R2 and R3 are selected from fluorine atom, hydroxyl, hydrogen atom and methoxy independently. The ezetimibe analogue is an ideal inhibitor for sucking cholesterol, and the cholesterol inhibitor can obviously prevent Caco-2 cells from sucking the cholesterol, so that the ezetimibe analogue has the prospect of becoming the inhibitor for sucking the cholesterol.

Description

technical field [0001] The invention belongs to the field of cholesterol absorption inhibitors and preparation thereof, in particular to an ezetimibe analogue and a preparation method thereof. Background technique [0002] A major risk factor for atherosclerosis and coronary heart disease is hypercholesterolemia. Although diet adjustment has a certain control effect on hyperlipidemia, most patients still need drug treatment in the end. A large number of clinical studies have confirmed that statin lipid-lowering drugs can significantly improve blood lipid disorders, and can reduce the morbidity and mortality of cardiovascular diseases, but due to the adverse reactions of large doses of statin drugs or differences in patient sensitivity, many patients fail to reach the goal. to the ideal lipid-lowering target. In 2002, Ezetimibe (SCH58235) was officially launched in the United States as a new type of cholesterol absorption inhibitor. It can be used alone or in combination wi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D205/08A61P3/06
Inventor 卿凤翎刘应乐黄焰根
Owner DONGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap